Related Experiment Video
Updated: Aug 29, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Cystatin C is associated with adverse COVID-19 outcomes in diverse populations
Sam O Kleeman1, Mattia Cordioli2, Paul R H J Timmers3,4
1Cold Spring Harbor Laboratory, Cold Spring Harbor, One Bungtown Road, New York, NY 11724, USA.
Insights
A polygenic score for Cystatin C (CyC) production is linked to critical COVID-19 illness. Longitudinal CyC levels also predict COVID-19 mortality, suggesting CyC
Area of Science:
- Genetics
- Immunology
- Infectious Diseases
Background:
- COVID-19 presents with diverse clinical outcomes, necessitating prognostic host factor identification.
- Understanding host factors is crucial for predicting severe COVID-19 and guiding patient management.
Purpose of the Study:
- To investigate the association between a polygenic score (PGS) for Cystatin C (CyC) production and critical illness in COVID-19 patients.
- To evaluate the predictive value of longitudinal plasma CyC levels for COVID-19 outcomes, including mortality.
Main Methods:
- Logistic regression analysis was used to assess the association between CyC-production PGS and ICU admission across four cohorts.
- Plasma proteomics and longitudinal CyC levels were analyzed in independent cohorts of hospitalized COVID-19 patients.
Main Results:
- A significant association was found between CyC-production PGS and the odds of critical COVID-19 illness across diverse populations.
- The strongest association was observed in the UK Biobank cohort (OR 2.13, p=7.12e-7).
- Plasma CyC levels were significantly associated with COVID-19 specific mortality (p=0.0007) in hospitalized patients.
Conclusions:
- Cystatin C (CyC) production-related genetic factors are associated with severe COVID-19 outcomes.
- Plasma CyC levels may serve as a prognostic biomarker for stratifying COVID-19 patients.
- CyC appears to play a functional role in the host's response to SARS-CoV-2 infection.
Abstract:
COVID-19 has highly variable clinical courses. The search for prognostic host factors for COVID-19 outcome is a priority. We performed logistic regression for ICU admission against a polygenic score (PGS) for Cystatin C (CyC) production in patients with COVID-19. We analyzed the predictive value of longitudinal plasma CyC levels in an independent cohort of patients hospitalized with COVID-19. In four cohorts spanning European and African ancestry populations, we identified a significant association between CyC-production PGS and odds of critical illness (n cases=2,319), with the strongest association captured in the UKB cohort (OR 2.13, 95% CI 1.58-2.87, p=7.12e-7). Plasma proteomics from an independent cohort of hospitalized COVID-19 patients (n cases = 131) demonstrated that CyC production was associated with COVID-specific mortality (p=0.0007). Our findings suggest that CyC may be useful for stratification of patients and it has functional role in the host response to COVID-19.
Related Concept Videos
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Cystic Fibrosis: Management
Sinus disease and chronic...

